July 27th, 2010 by Medgadget in Better Health Network, News, Research
No Comments »
FDA researchers have published a study in Pediatrics that analyzed patient records from child and teen ER visits in 2004 and 2005. The investigators are reporting that 70,000 kids each year go to the ER because of issues caused by medical devices.
About a quarter of the injuries were from contact lenses, while the other major contributors were needles, wheelchairs, braces, and obstetric exam tools. The study also looked at the devices most likely to cause hospitalization, and they were found to be mostly invasive devices like ostomy appliances and implanted defibrillators. Read more »
*This blog post was originally published at Medgadget*
July 22nd, 2010 by AndrewSchorr in Better Health Network, Health Policy, News, Opinion, Quackery Exposed, Research
1 Comment »
The news wasn’t good this week for women concerned about breast cancer.
First came the story that some women were diagnosed with breast cancer, very early stage, had treatment –- including disfiguring surgery -– and then found out they never had cancer in the first place. The pathologist goofed, maybe even a second pathologist also misread the biopsies.
How does this happen? Not surprisingly it comes back to the clinical experience of the doctor. Properly diagnosing breast cancer, whether through radiology scans or pathology biopsies is not always easy. And in many communities the general radiologists and pathologists just don’t have enough specialized experience. This leads to mistakes, especially when the suggestions of possible cancer are subtle and minute. Read more »
*This blog post was originally published at Andrew's Blog*
July 19th, 2010 by JenniferKearneyStrouse in Better Health Network, Health Policy, News
No Comments »
An FDA advisory panel has voted that the diabetes drug Avandia (rosiglitazone) can remain on the market, but recommended further warnings associated with its use. The panel was divided, the New York Times reported, with 12 of 33 members saying the drug should be removed from the market, 10 voting to restrict sales and strengthen the warning label, 7 recommending only strengthening the warning label, and 3 voting for no change. One panel member abstained. (New York Times)
The White House yesterday announced which preventive services would be available at no charge to patients under the new healthcare legislation. Adult patients who choose a health plan after September 23 will receive mammograms, diabetes screening, and tobacco cessation counseling, among other services, at no increased cost, but insurers have said patients will eventually pay in the form of higher premiums, the Wall Street Journal reported. (Wall Street Journal)
*This blog post was originally published at ACP Internist*
July 12th, 2010 by AndrewSchorr in Better Health Network, Health Policy, News, Opinion, Research
No Comments »
They have a tough job, those government doctors, scientists, and bureaucrats who are charged with assessing the safety and effectiveness of proposed new medical products. As you know, they rely largely on studies presented by the applicants.
The Food and Drug Administration (FDA) has the power to not approve a new drug or product or even pull it off the market. Right now it is considering limiting or pulling GlaxoSmithKline’s (GSK) diabetes drug, Avandia, because of newly discovered data that it may have caused heart attack in some patients –- data mysteriously not shown in GSK’s own studies. If the drug is pulled it will cost GSK billions of dollars in lost revenue but, from the FDA’s point-of-view, it will be protecting the public. And, after all, there are safer diabetes drugs on the market as alternatives. Read more »
*This blog post was originally published at Andrew's Blog*
July 12th, 2010 by GarySchwitzer in Better Health Network, Health Policy, News, Opinion
No Comments »
Kaiser Health News proves its value once again with an under-the-radar story covering some items you won’t see in many other news sources. An excerpt:
“…several lesser-known provisions also take effect in coming months that could have a lasting impact on the nation’s health care system.
These provisions include eliminating patients’ co-payments for certain preventive services such as mammograms, giving the government more power to review health insurers’ premium increases and allowing states to expand Medicaid coverage to low-income adults without children.
While these changes might not have gotten at lot of attention, they could help build support for the law in the run-up to the contentious mid-term elections.”
Their list:
• Prevention For Less
• Knowing Which Treatments Work Best
• Helping Cover Early Retirees’ Health Costs
• Keeping Tabs on Health Insurance Premiums
• Expanded Medicaid Coverage
• Care Coordination for ‘Dual Eligibles’
• FDA Approval For ‘Follow-On Biologics’
Read the full story at the link above for details.
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
